The EMJ Podcast | Bonus Episode
In this bonus episode of the EMJ Podcast, host Brigitte Scott is joined by Ketta Lorusso, Humanitas University, Milan, Italy; and Rob Coleman, Vaniam Group, Chicago, Illinois, USA, who discuss key developments in endometrial cancer research that were presented in 2023.
Spotify | Apple | Amazon Music | Download MP3 (41:59 mins)
This podcast was funded by a medical educational grant from GSK, with the purpose of enhancing the fundamental understanding of oncology specialists of key data and the latest advancements in endometrial cancer care. This content is not intended for US Healthcare Professionals.
Speakers
Ketta Lorusso, Professor, Humanitas University, Milan, Italy
“…in a metastatic disease, if you have no more events in 2 years or 3 years, I think we can consider this patient cured, and this is incredible…my dream is to cure patients, and probably we are very close to doing that.”
Rob Coleman, Chief Medical Officer, Vaniam Group, Chicago, Illinois, USA
“[The data are] unprecedented and have really had a profound effect. When [these results] were presented at the meeting, they were met with a standing ovation…and to listen to a patient stand up and congratulate the audience for their dedication…really drives home the value of what it is that we do with clinical research.”
